DK157976C - Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre - Google Patents

Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre

Info

Publication number
DK157976C
DK157976C DK048382A DK48382A DK157976C DK 157976 C DK157976 C DK 157976C DK 048382 A DK048382 A DK 048382A DK 48382 A DK48382 A DK 48382A DK 157976 C DK157976 C DK 157976C
Authority
DK
Denmark
Prior art keywords
piperazinylethymidoylamidoid
heptan
thia
azabicyclo
dioxo
Prior art date
Application number
DK048382A
Other languages
Danish (da)
English (en)
Other versions
DK48382A (da
DK157976B (da
Inventor
Bruce Edwin Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK157976(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK48382A publication Critical patent/DK48382A/da
Publication of DK157976B publication Critical patent/DK157976B/da
Application granted granted Critical
Publication of DK157976C publication Critical patent/DK157976C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK048382A 1981-03-26 1982-02-04 Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre DK157976C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26
US24758681 1981-03-26

Publications (3)

Publication Number Publication Date
DK48382A DK48382A (da) 1982-09-27
DK157976B DK157976B (da) 1990-03-12
DK157976C true DK157976C (da) 1990-08-27

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048382A DK157976C (da) 1981-03-26 1982-02-04 Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre

Country Status (23)

Country Link
JP (1) JPS57159708A (de)
AT (1) AT395533B (de)
AU (1) AU549784B2 (de)
BE (1) BE892541A (de)
CA (1) CA1209477A (de)
CH (1) CH652306A5 (de)
DE (2) DE19375106I2 (de)
DK (1) DK157976C (de)
ES (1) ES8302455A1 (de)
FR (1) FR2502624B1 (de)
GB (1) GB2095551B (de)
GR (1) GR78386B (de)
HK (1) HK39189A (de)
HU (1) HU186489B (de)
IE (1) IE52936B1 (de)
IL (1) IL64924A (de)
IT (1) IT1147916B (de)
LU (1) LU84031A1 (de)
NL (1) NL192664C (de)
NZ (1) NZ199632A (de)
PL (1) PL130564B1 (de)
SE (1) SE453153B (de)
ZA (1) ZA82605B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
EP1675573B2 (de) 2003-10-23 2012-06-13 Otsuka Pharmaceutical Co., Ltd. Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
NZ582415A (en) 2007-07-31 2012-05-25 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
DE3208505C2 (de) 1991-11-28
ES509234A0 (es) 1982-12-16
IE52936B1 (en) 1988-04-13
IT8248034A0 (it) 1982-03-19
JPH0219804B2 (de) 1990-05-07
NZ199632A (en) 1985-07-12
DE3208505A1 (de) 1982-10-21
FR2502624B1 (fr) 1985-10-25
GB2095551A (en) 1982-10-06
CA1209477A (en) 1986-08-12
SE453153B (sv) 1988-01-18
DK48382A (da) 1982-09-27
NL192664C (nl) 1997-12-02
ES8302455A1 (es) 1982-12-16
BE892541A (fr) 1982-09-20
HK39189A (en) 1989-05-19
FR2502624A1 (fr) 1982-10-01
GB2095551B (en) 1984-10-03
IE820703L (en) 1982-09-26
CH652306A5 (de) 1985-11-15
SE8200591L (sv) 1982-09-27
PL235509A1 (de) 1982-12-20
NL8201251A (nl) 1982-10-18
ATA92982A (de) 1992-06-15
AU549784B2 (en) 1986-02-13
JPS57159708A (en) 1982-10-01
GR78386B (de) 1984-09-26
IL64924A0 (en) 1982-04-30
DK157976B (da) 1990-03-12
AT395533B (de) 1993-01-25
HU186489B (en) 1985-08-28
IT1147916B (it) 1986-11-26
AU7986582A (en) 1982-09-30
NL192664B (nl) 1997-08-01
ZA82605B (en) 1982-12-29
PL130564B1 (en) 1984-08-31
IL64924A (en) 1985-07-31
DE19375106I2 (de) 2006-02-16
LU84031A1 (de) 1982-07-08

Similar Documents

Publication Publication Date Title
DK158873C (da) Fremgangsmaade til stabilisering af et lyofiliseret farmaceutisk interferonpraeparat
ES518574A0 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK84082A (da) Fremgangsmaade til fremstilling af pg12-derivater
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
FI90430C (fi) Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi
DK453882A (da) Fremgangsmaade til fremstilling af triazinderivater
DK585985A (da) Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af amyotrof lateralsklerose
DK453982A (da) Fremgangsmaade til fremstilling af oligosaccharidderivater
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK353781A (da) Fremgangsmaade til fremstilling af insulinderivater
IT8224053A0 (it) Procedimento per la preparazione di derivati di eburnamonina.
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
DK157976C (da) Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK505482A (da) Fremgangsmaade til fremstilling af pyridinderivater
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
FI911701A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO822062L (no) Substituerte imidazo(1,5-alfa)pyridiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse
IT8123028A0 (it) Procedimento per la preparazione di percarbonato di sodio.
DK113483D0 (da) Fremgangsmade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
ES510913A0 (es) "un procedimiento para la preparacion de derivados de piridina".
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.